5.3.2021 16:20:43 CET | Demant A/S |
Forløb af generalforsamling
Selskabsmeddelelse nr. 2021-04
5. marts 2021
Afholdelse af ordinær generalforsamling
Demant A/S har i dag afholdt ordinær generalforsamling som et fuldt elektronisk møde. Alle bestyrelsens forslag blev vedtaget af generalforsamlingen. Dette medførte blandt andet følgende beslutninger:
At selskabets årsrapport for 2020 blev godkendt, og at hele årets overskud, DKK 789 , overføres til selskabets reserver.
At vederlagsrapporten for 2020 blev godkendt.
At den foreslåede forhøjelse af bestyrelseshonoraret blev vedtaget.
At Niels B. Christiansen, Niels Jacobsen og Anja Madsen blev genvalgt som bestyrelsesmedlemmer.
At Sisse Fjelsted Rasmussen og Kristian Villumsen blev valgt som nye bestyrelsesmedlemmer.
At selskabets revisionsfirma, Deloitte Statsautoriseret Revisionspartnerselskab, blev genvalgt.
At selskabets aktiekapital nedsættes med nominelt DKK 112.667 svarende til selskabets beholdning af egne aktier pr. 10. februar 2021. Beholdningen af egne aktier er erhvervet som led i selskabets aktietilbagekøb i 2020. Som konsekvens af kapitalnedsættelsen ændres vedtægternes pkt. 4.1 senest fire uger efter udløbet af fristen for kreditorers anmeldelse af krav, således at det herefter af pkt. 4.1 vil fremgå, at selskabets aktiekapital udgør DKK 025.566,60.
At bestyrelsen blev bemyndiget til indtil næste ordinære generalforsamling at lade selskabet tilbagekøbe aktier med en pålydende værdi af indtil 10 % af aktiekapitalen.
At vedtægterne tilføjes et nyt punkt om præsentation af og vejledende afstemning om vederlagsrapporten, som føjes til dagsordenen for den ordinære generalforsamling.
At offentliggørelse af information i henhold til gældende børslovgivning, herunder selskabsmeddelelser, kan ske udelukkende på engelsk.
At der indføres mulighed for at afholde fuldstændigt elektronisk generalforsamling.
At bestyrelsen indtil den 1. marts 2026 blev bemyndiget til at forhøje selskabskapitalen som følger:
Udstedelse af nye aktier i én eller flere udstedelser med fortegningsret for selskabets eksisterende aktionærer og med en samlet nominel værdi på op til DKK 4.800.000.
Udstedelse af nye aktier i én eller flere udstedelser uden fortegningsret for selskabets eksisterende aktionærer og med en samlet nominel værdi på op til DKK 4.800.000, forudsat at forhøjelsen sker til markedsværdi. Bemyndigelserne til bestyrelsen efter dette og ovenstående punkt kan tilsammen maksimalt udnyttes ved udstedelse af nye aktier med en samlet nominel værdi på DKK 4.800.000.
Udstedelse af nye aktier i én eller flere udstedelser uden fortegningsret for selskabets eksisterende aktionærer og med en samlet nominel værdi på op til DKK 2.500.000, i forbindelse med at de nye aktier tilbydes medarbejderne i selskabet og medarbejderne i de selskaber, der af bestyrelsen anses for knyttet til selskabet.
I sin tale på generalforsamlingen redegjorde bestyrelsens formand, Niels B. Christiansen, for koncernens udvikling i 2020. Beretningen er tilgængelig på demant.com. I sin tale sagde formanden blandt andet:
“2020 var et ganske specielt år, hvor markedet for høresundhedsløsninger blev voldsomt påvirket af restriktionerne i samfundet som følge af coronavirus. Det var særligt i første halvår, at Demant og industrien var hårdt ramt, mens koncernen i andet halvår leverede betydelig bedring. Året igennem oplevede Demants headset-forretning med det nye brand, EPOS, positiv medvind som følge af øget behov for at samarbejde virtuelt og levede i den grad op til vores vækstambitioner. Det er med stolthed, at jeg har set hele vores globale organisation lykkes med at styre Demant sikkert igennem et usædvanligt år ved at balancere omkostningsbesparelser og kontinuerligt holde fokus på at levere førsteklasses produkter og services til vores kunder,” sagde bestyrelsesformand Niels B. Christiansen og tilføjede en bred tak til alle selskabets interessenter.
“Jeg vil gerne takke alle Demants interessenter globalt: Brugere, der er loyale og har vist os tillid, kunder, leverandører og medarbejdere, der er dedikeret til at få tingene til at fungere i vanskelige tider samt investorer, banker, lokale myndigheder, politikere og samfundet som helhed, der har understøttet fundamentet for at opretholde vores investeringer i fremtiden.”
Efter generalforsamlingen konstituerede bestyrelsen sig med Niels B. Christiansen som formand og Niels Jacobsen som næstformand.
Yderligere information:
Adm. direktør Søren Nielsen
Telefon +45 3917 7300
www.demant.com
Øvrige kontaktpersoner:
CFO René Schneider
IR-chef Mathias Holten Møller
IR Officer Christian Lange
Kommunikationschef Trine Kromann-Mikkelsen
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
2021-04 Afholdelse af generalforsamling.pdf
5.3.2021 16:20:43 CET | Demant A/S |
Decisions of general meeting
Company announcement no 2021-04
5 March 2021
Annual general meeting
Today, Demant A/S held its annual general meeting as a fully virtual meeting. All proposals put forward by the Board were adopted by the general meeting, implying among others the following decisions:
The company’s Annual Report 2020 was approved, and the year’s profit, DKK 789 million, will be transferred to the company’s reserves.
The remuneration report for 2020 was approved.
The proposed increase of the Director’s fee was approved.
Niels B. Christiansen, Niels Jacobsen and Anja Madsen were re-elected members of the Board of Directors.
Sisse Fjelsted Rasmussen and Kristian Villumsen were elected new members of the Board of Directors.
The company’s auditors, Deloitte Statsautoriseret Revisionspartnerselskab, were re-elected.
The company’s share capital will be reduced by nominally DKK 112,667, corresponding to the company’s holding of treasury shares at 10 February 2021. The company’s holding of treasury shares was acquired during 2020 as part of the company’s share buy-back scheme. As a result of the capital reduction, article 4.1 of the articles of association will be amended no later than four weeks after expiry of the deadline for the filing of claims by creditors, which means that upon expiry of this deadline, it will appear from article 4.1 that the company’s share capital is DKK 48,025,566.60.
Until the next ordinary general meeting, the Board was authorised to let the company buy back shares with a nominal value of up to 10% of the share capital.
A new article will be added to the company’s articles of association regarding the presentation of and advisory voting on the remuneration report, which will be put on the agenda for the annual general meeting.
It is now possible to publish information under applicable Danish stock exchange legislation, including company announcements, in English only.
Conducting fully virtual annual general meetings is now possible.
Until 1 March 2026, the Board of Directors was authorised to increase the company’s share capital as follows:
By issuing – through one or more issues – new shares with preferential rights of subscription for the company’s existing shareholders and with a total nominal value of up to DKK 4,800,000.
By issuing – through one or more issues – new shares without preferential rights of subscription for the company’s existing shareholders and with a total nominal value of up to DKK 4,800,000, provided that the increase is made at market value. The Board of Directors’ authorisations under this and the above bulletpoint may only be exercised in aggregate by way of issuing new shares with a total nominal value of DKK 4,800,000.
By issuing – through one or more issues – new shares without preferential rights of subscription for the company’s existing shareholders and with a total nominal value of up to DKK 2,500,000 in connection with the new shares being offered to employees of the company and of any company which the Board of Directors regards as being affiliated with the company.
In his address, the Chairman of the Board, Niels B. Christiansen, gave an account of the Group’s development in 2020. The report is available on demant.com. He said among other things:
“2020 was a very special year where the market for hearing healthcare solutions was severely impacted by the restrictions imposed on society due to coronavirus. Demant and the industry in general were particularly hard hit in the first half-year, whereas the Group saw strong recovery in the second half. Throughout the year, our headset business operating under the new brand, EPOS, experienced strong tailwinds due to the increased need for collaborating virtually and lived very much up to our growth ambitions. I am proud to see that our entire global organisation has succeeded in steering Demant safely through an unusual year by balancing cost savings, while continuing to focus on delivering top-notch products and services to our customers,” says Niels B. Christiansen, Chairman of the Board of Directors, and added a broad thank you to all the company’s stakeholders.
“I would like to thank all Demant’s stakeholders globally: Our loyal users, who on a daily basis show us trust, customers, suppliers and employees, who are all dedicated to making things work in difficult times, as well as investors, banks, local authorities, politicians and society in general, which have all supported the foundation for maintaining our investments in the future.”
After the general meeting, the Board of Directors elected Niels B. Christiansen Chairman and Niels Jacobsen Deputy Chairman of the Board.
Further information:
Søren Nielsen, President & CEO
Phone +45 3917 7300
www.demant.com
Other contacts:
René Schneider, CFO
Mathias Holten Møller, Head of IR
Christian Lange, IR Officer
Trine Kromann-Mikkelsen, VP Corporate Communication and Relations
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
2021-04 Annual general meeting.pdf
